These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6697076)

  • 1. Unbound plasma salicylate concentration in rheumatoid arthritis patients.
    Gurwich EL; Raees SM; Skosey J; Niazi S
    Br J Rheumatol; 1984 Feb; 23(1):66-73. PubMed ID: 6697076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concentration dependent plasma protein binding of salicylate in rheumatoid patients.
    Ekstrand R; Alvan G; Borga O
    Clin Pharmacokinet; 1979; 4(2):137-43. PubMed ID: 378501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood and saliva salicylate measurement in the monitoring of salicylate therapy.
    Pérez-Mateo M; Erill S; Cabezas R
    Int J Clin Pharmacol Biopharm; 1977 Mar; 15(3):113-5. PubMed ID: 844929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decrease of in vitro serum protein binding of salicylate in rheumatoid arthritis.
    Netter P; Monot C; Stalars MC; Mur JM; Royer RJ; Faure G; Pourel J; Martin J; Gaucher A
    Eur J Drug Metab Pharmacokinet; 1984; 9(2):109-16. PubMed ID: 6745302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma salicylate levels in rheumatoid arthritis produced by four different salicylate preparations.
    Brick DL; Corrigan AB
    Med J Aust; 1970 Aug; 2(8):382-3. PubMed ID: 5457655
    [No Abstract]   [Full Text] [Related]  

  • 6. [Protein binding of salicylates in rheumatoid arthritis].
    Netter P; Monot C; Stalars MC; Mur JM; Royer RJ; Pourel J; Faure G; Martin J; Gaucher A
    Rev Rhum Mal Osteoartic; 1982 May; 49(6):447-52. PubMed ID: 7112023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salicylate pharmacokinetics in patients with rheumatoid arthritis.
    Owen SG; Roberts MS; Friesen WT; Francis HW
    Br J Clin Pharmacol; 1989 Oct; 28(4):449-61. PubMed ID: 2590603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma salicylate levels in rheumatoid arthritis produced by four different salicylate preparations.
    Armstrong BK; Urich AW; Goatcher PM
    Med J Aust; 1970 Oct; 2(14):653-4. PubMed ID: 5477813
    [No Abstract]   [Full Text] [Related]  

  • 9. Symptomatic salicylate ototoxicity: a useful indicator of serum salicylate concentration?
    Halla JT; Atchison SL; Hardin JG
    Ann Rheum Dis; 1991 Oct; 50(10):682-4. PubMed ID: 1958090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum concentrations of salicylate and naproxen during concurrent therapy in patients with rheumatoid arthritis.
    Furst DE; Sarkissian E; Blocka K; Cassell S; Dromgoole S; Harris ER; Hirschberg JM; Josephson N; Paulus HE
    Arthritis Rheum; 1987 Oct; 30(10):1157-61. PubMed ID: 3675660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inability to interpret toxic salicylate levels in patients taking aspirin and diflunisal.
    Adelman HM; Wallach PM; Flannery MT
    J Rheumatol; 1991 Apr; 18(4):522-3. PubMed ID: 2066942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma salicylate levels in rheumatoid arthritis produced by four different salicylate preparations.
    Armstrong BK; Ukich AW; Goatcher PM
    Med J Aust; 1970 Jul; 2(4):181-3. PubMed ID: 4917130
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetic monitoring of salicylate therapy in children with juvenile rheumatoid arthritis.
    Pachman LM; Olufs R; Procknal JA; Levy G
    Arthritis Rheum; 1979 Aug; 22(8):826-31. PubMed ID: 465097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled trial of clinical utility of serum salicylate monitoring in rheumatoid arthritis.
    Tugwell P; Hart L; Kraag G; Park A; Dok C; Bianchi F; Goldsmith C; Buchanan WW
    J Rheumatol; 1984 Aug; 11(4):457-61. PubMed ID: 6481719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Enteric aspirin tablets and the salicylate concentration in the plasma in the morning].
    Laine V; Strandman D; Tikkanen R
    Lakartidningen; 1968 Sep; 65(39):3832-7 passim. PubMed ID: 5741894
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasma and synovial fluid gentisate in patients receiving salicylate therapy.
    Cleland LG; Lowthian PJ; Imhoff D; Bochner F; Betts WH; O'Callaghan J
    J Rheumatol; 1985 Feb; 12(1):136-9. PubMed ID: 3981499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparable serum salicylate concentrations from choline magnesium trisalicylate, aspirin, and buffered aspirin in rheumatoid arthritis.
    Binus MH; Lyon JA; Nicholas JL
    Arthritis Rheum; 1982 Apr; 25(4):464-6. PubMed ID: 7073776
    [No Abstract]   [Full Text] [Related]  

  • 18. Transient fall in serum salicylate levels following intraarticular injection of steroid in patients with rheumatoid arthritis.
    Baer PA; Shore A; Ikeman RL
    Arthritis Rheum; 1987 Mar; 30(3):345-7. PubMed ID: 3566826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid fluorometric analysis of unbound salicylate in whole blood.
    Baselt RC; Stewart CB
    Res Commun Chem Pathol Pharmacol; 1976 Oct; 15(2):351-60. PubMed ID: 981790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salicylate ototoxicity in patients with rheumatoid arthritis: a controlled study.
    Halla JT; Hardin JG
    Ann Rheum Dis; 1988 Feb; 47(2):134-7. PubMed ID: 3281604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.